Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
Characteristics of essential thrombocythemia
Question 1 of 5
Topics
Myelodysplastic Syndrome
Myelodysplastic Syndrome
| Quiz | |
|---|---|
| Pathophysiology of myelodysplastic syndrome | Take Quiz |
| ALL: Diagnosis, imaging, & treatment | Take Quiz |
| ALL: Clinical features & diagnosis | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| Chronic myelomonocytic leukemia: Survival after transplant | Take Quiz |
Bleeding Disorders
Bleeding Disorders
| Quiz | |
|---|---|
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Pathophysiology of hemophilia | Take Quiz |
| Hereditary hemorrhagic telangiectasia | Take Quiz |
| Forms of Von Willebrand disease | Take Quiz |
| Sickle cell disease: Acute exacerbations | Take Quiz |
| Sickle cell disease: Diagnosis & management | Take Quiz |
| Sickle cell disease: Signs, symptoms, & diagnosis | Take Quiz |
| Thrombotic thrombocytopenic purpura in adults | Take Quiz |
| Disseminated intravascular coagulation risk factors | Take Quiz |
| Disseminated intravascular coagulation: Pathophysiology | Take Quiz |
| von Willebrand disease: Diagnosis & treatment | Take Quiz |
| von Willebrand disease: Epidemiology & clinical features | Take Quiz |
| The source of hematopoietic stem cells | Take Quiz |
| Bone marrow transplantation: Conditioning modalities & donor options | Take Quiz |
| Drug-induced platelet dysfunction | Take Quiz |
| Disorders of fibrinolysis: Clinical features | Take Quiz |
| Antithrombin deficiency | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| Pancytopenia: Patient history & features | Take Quiz |
| Sickle cell trait & HBA1c in African Americans | Take Quiz |
| Hemophilia A and B: Characteristics & diagnosis | Take Quiz |
| Sickle cell trait, rhabdomyolysis, and mortality | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Classification of von Willebrand disease | Take Quiz |
| Treatment of von Willebrand disease | Take Quiz |
| Pathophysiology of hemophilia A and B | Take Quiz |
| Clinical manifestations of hemophilia | Take Quiz |
| GVHD: Laboratory & imaging studies | Take Quiz |
Thrombosis
Thrombosis
| Quiz | |
|---|---|
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Characteristics of essential thrombocythemia | Take Quiz |
| Pathogenesis of immune thrombocytopenia | Take Quiz |
| ISTH Guidance Statement: Identifying & preventing VTE in pediatric cancer | Take Quiz |
| Antiphospholipid antibody syndrome: Diagnosis & management | Take Quiz |
| Thrombotic thrombocytopenic purpura in adults | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Thrombosis | Take Quiz |
| Thrombocytopenia diagnosis | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Prognosis & reducing complications | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Management | Take Quiz |
| Diagnosing paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Signs & symptoms of paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Thrombosis pathophysiology, risk factors, & prognosis | Take Quiz |
| Clinical features of thrombosis | Take Quiz |
| Disorders of fibrinolysis: Clinical features | Take Quiz |
| Antithrombin deficiency | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| Etiologies of thrombosis | Take Quiz |
| ASH Guidelines: Subsequent management of ITP | Take Quiz |
| ASH Guidelines: Initial management of immune thrombocytopenia | Take Quiz |
| ASH Guidelines: Typical features & diagnosis of immune thrombocytopenia | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 1 | Take Quiz |
Anemia
Anemia
| Quiz | |
|---|---|
| Overview of beta-thalassemia | Take Quiz |
| Overview of aplastic anemia | Take Quiz |
| Overview of alpha thalassemia | Take Quiz |
| Signs, symptoms, and staging of iron deficiency anemia | Take Quiz |
| Pathophysiology of iron deficiency anemia | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Thrombosis | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Prognosis & reducing complications | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Management | Take Quiz |
| Diagnosing paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Signs & symptoms of paroxysmal nocturnal hemoglobinuria | Take Quiz |
| The source of hematopoietic stem cells | Take Quiz |
| Bone marrow transplantation: Conditioning modalities & donor options | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Alpha thalassemia: Management | Take Quiz |
| Types of alpha thalassemia | Take Quiz |
| Alpha-Thalassemias: Characteristics & diagnosis | Take Quiz |
| Alpha thalassemia: Physical findings & diagnosis | Take Quiz |
| Drug-induced hemolysis: Pathophysiology, diagnosis, & treatment | Take Quiz |
| Prognosis & management of megaloblastic anemia | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Anemia in adults | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| Anemia in children | Take Quiz |
| Diagnosis of anemia | Take Quiz |
| Mechanisms of anemia | Take Quiz |
| Drug-induced hemolysis: Clinical features | Take Quiz |
| Diagnosis of megaloblastic anemia | Take Quiz |
AML
AML
| Quiz | |
|---|---|
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
| AML prognosis & survival | Take Quiz |
| Classification of adult AML | Take Quiz |
| Donor lymphocyte infusion | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| AML: Features & diagnosis | Take Quiz |
| AML: Androgen maintenance therapy & survival | Take Quiz |
| Leukemia: Survival after cord-blood transplant | Take Quiz |
| Telomere length and delayed bone marrow recovery in pediatric AML | Take Quiz |
| Extramedullary disease & AML survival | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
| Quiz | |
|---|---|
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
Indolent Lymphoma
Indolent Lymphoma
| Quiz | |
|---|---|
| Overview of chronic lymphocytic leukemia | Take Quiz |
| About Waldenstrom macroglobulinemia | Take Quiz |
| Subtypes of marginal zone lymphoma | Take Quiz |
| Subtypes of indolent lymphoma | Take Quiz |
| Mycosis fungoides: Systemic implications & complications | Take Quiz |
| Follicular lymphoma imaging, management, & differential diagnosis | Take Quiz |
| Waldenstrom’s macroglobulinemia: Prevalence, features, & diagnosis | Take Quiz |
| Risk factors for developing marginal zone lymphoma | Take Quiz |
| Familial predisposition & genomic aberrations in WM | Take Quiz |
| MALT lymphoma: Features & biology | Take Quiz |
| Prognostic factors in follicular lymphoma | Take Quiz |
| Mycosis fungoides: Risk factors & clinical features | Take Quiz |
| Mycosis fungoides: Early stages & treatment | Take Quiz |
| Nodal marginal zone lymphoma: Epidemiology & clinical presentation | Take Quiz |
| Splenic marginal zone lymphoma: Features, diagnosis, & management | Take Quiz |
| Indolent B-cell lymphoma: Autologous & allogeneic stem cell transplantation | Take Quiz |
| Waldenström’s macroglobulinemia & stem cell transplantation | Take Quiz |
| Characteristics across indolent NHL subtypes | Take Quiz |
| Follicular lymphoma: Characteristics & diagnosis | Take Quiz |
| Marginal zone lymphoma subtypes | Take Quiz |
| Mycosis fungoides: Clinical presentation, prognosis, & survival | Take Quiz |
| A subset of indolent lymphomas: Features & outcomes | Take Quiz |
| Waldenstrom’s macroglobulinemia: Prognostic factors | Take Quiz |
| Mass cytometry study of follicular lymphoma tumors reveals cellular characteristics | Take Quiz |
| Cutaneous B-cell lymphoma: Epidemiology & diagnosis | Take Quiz |
| Marginal zone lymphoma & primary cutaneous anaplastic large cell lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Marginal zone lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Lymphoplasmacytic lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Follicular lymphoma | Take Quiz |
| Waldenström macroglobulinemia: Symptoms & criteria for treatment | Take Quiz |
Mixed Topics
Mixed Topics
| Quiz | |
|---|---|
| Lymphocytopenia: Signs & symptoms, diagnosis, & treatment | Take Quiz |
| Causes of lymphocytopenia | Take Quiz |
| Therapies for hemophagocytic lymphohistiocytosis | Take Quiz |
| Hemophagocytic lymphohistiocytosis: Diagnosis & prognosis | Take Quiz |
| Hemophagocytic syndrome & risk | Take Quiz |
| Cancer survivors: Medication use for anxiety & depression | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| Hydroxyurea & transfusion therapy for sickle cell disease | Take Quiz |
| MGUS risk & diagnosis | Take Quiz |
| Complications of sickle cell disease | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
ALL (Acute Lymphoblastic Leukemia)
ALL (Acute Lymphoblastic Leukemia)
| Quiz | |
|---|---|
| Acute leukemia: Initial diagnostic workup | Take Quiz |
| Donor lymphocyte infusion | Take Quiz |
| ALL: Diagnosis, imaging, & treatment | Take Quiz |
| ALL: Clinical features & diagnosis | Take Quiz |
| Guidelines: Diagnostic workup of acute leukemia | Take Quiz |
| NCHS Report: Pediatric cancer rates | Take Quiz |
| Ph-like ALL in adults | Take Quiz |
| Acute leukemia: Epidemiology & pathophysiology | Take Quiz |
| Clinical signs & symptoms of acute leukemia | Take Quiz |
| Initial management & tumor lysis syndrome in acute leukemia | Take Quiz |
Hematology
Hematology
| Quiz | |
|---|---|
| MGUS risk & diagnosis | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
CML
CML
| Quiz | |
|---|---|
| Chronic myeloid leukemia: Risk & prognosis | Take Quiz |
| Chronic myeloid leukemia: Management | Take Quiz |
| Chronic myeloid leukemia: Pathogenesis | Take Quiz |
| Chronic myeloid leukemia: Symptoms & diagnosis | Take Quiz |
| CML: TKI adherence | Take Quiz |
Multiple Myeloma
Multiple Myeloma
| Quiz | |
|---|---|
| Multiple myeloma: M-proteins & clinical features | Take Quiz |
| Multiple myeloma signs, symptoms, and diagnosis | Take Quiz |
| Multiple myeloma: Genetic factors & risk groups | Take Quiz |
| Multiple myeloma: Initial evaluation | Take Quiz |
| Staging multiple myeloma | Take Quiz |
| Identifying multiple myeloma | Take Quiz |
| Relapsed multiple myeloma: Features & treatment | Take Quiz |
| Multiple myeloma: Pathophysiology, diagnosis, & laboratory tests | Take Quiz |
| Multiple myeloma prognosis | Take Quiz |
| Emergent conditions associated with multiple myeloma | Take Quiz |
| Multiple myeloma: Laboratory & imaging studies | Take Quiz |
| Multiple myeloma: Key features & risk factors | Take Quiz |
| Diagnostic criteria for multiple myeloma | Take Quiz |
| Multiple myeloma: Diagnosis, staging, & risk stratification | Take Quiz |
| Pathogenesis of multiple myeloma | Take Quiz |
| Multiple myeloma: Epidemiology & features | Take Quiz |
| Myeloma survival: Post-transplant response and minimal residual disease | Take Quiz |
| Multiple myeloma outcomes: Lower- & higher-volume facilities | Take Quiz |
| Multiple myeloma: MRD & survival | Take Quiz |
| Smoldering multiple myeloma in the United States | Take Quiz |
| Prognosis of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: The basics | Take Quiz |
| Treatment of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: MGUS | Take Quiz |
| Clinical features of multiple myeloma | Take Quiz |
| Diagnosis and staging of multiple myeloma | Take Quiz |
Transfusion Medicine
Transfusion Medicine
| Quiz | |
|---|---|
| Drug-induced platelet dysfunction | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Platelet transfusion for GI bleeding in patients on antiplatelet agents | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| Transfusion: Age of blood & mortality | Take Quiz |
Cellular Therapy
Cellular Therapy
| Quiz | |
|---|---|
| Fungal infections after bone marrow transplant: Presenting features | Take Quiz |
| Diagnosing fungal infections after BMT | Take Quiz |
| Prognostic value of hematopoietic cell transplant comorbidity index | Take Quiz |
| Bacterial infections after bone marrow transplant | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| HSC donors & health-related quality of life | Take Quiz |
| HSCT outcomes & vancomycin-resistant enterococcus colonization & bacteremia | Take Quiz |
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
CLL
CLL
| Quiz | |
|---|---|
| Donor lymphocyte infusion | Take Quiz |
| CLL & minimal residual disease status | Take Quiz |
| CLL, genetic aberrations, & the elderly | Take Quiz |
| Molecular prognostic indicators in CLL | Take Quiz |
| CLL management & prognosis | Take Quiz |
| Diagnosis, classification, & prognostic factors of CLL | Take Quiz |
| CLL: Risk factors & prognostic factors | Take Quiz |
| Staging CLL | Take Quiz |
| Treatment of CLL | Take Quiz |
| Understanding CLL | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Understanding familial CLL | Take Quiz |
| Clinical manifestations of CLL | Take Quiz |
| Diagnosis of CLL | Take Quiz |
T Cell Lymphomas
T Cell Lymphomas
| Quiz | |
|---|---|
| Physical findings of mycosis fungoides | Take Quiz |
Aggressive Lymphomas
Aggressive Lymphomas
| Quiz | |
|---|---|
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
| HCV: Increased non-Hodgkin lymphoma risk? | Take Quiz |
| Non-Hodgkin lymphoma risk & HIV-Hepatitis coinfection | Take Quiz |
Mantle Cell Lymphoma
Mantle Cell Lymphoma
| Quiz | |
|---|---|
| MCL: Epidemiology, subtypes, & diagnosis | Take Quiz |
| MCL: Diagnosis, treatment, & prognosis | Take Quiz |
| Quiz | |
|---|---|
| Transformed indolent lymphoma and ASCT | Take Quiz |
| Genes & AML | Take Quiz |
| ALL outcomes in pediatric patients | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 2 | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 1 | Take Quiz |
| Classification of adult ALL | Take Quiz |
| HIV-related lymphomas and AHCT | Take Quiz |
| Adult HL treatment | Take Quiz |
| Diagnosis and assessment of ALL | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 3 | Take Quiz |
| Staging of adult HL | Take Quiz |
| Treatment of adult ALL | Take Quiz |
Lymphoma & Plasma Cell Disorders
Lymphoma & Plasma Cell Disorders
| Quiz | |
|---|---|
| Treatment of adult HL | Take Quiz |
| Diagnosis & pathogenesis of primary CNS lymphoma | Take Quiz |
| Indolent & aggressive NHL | Take Quiz |
| Cellular classification & treatment of NHL | Take Quiz |
| Understanding NHL | Take Quiz |
| Prognosis of primary CNS lymphoma | Take Quiz |
